Clinical Drug Experience Knowledgebase

capecitabine (xeloda) (6 trials)

lapatinib (tykerb) (2 trials)

nerlynx (41 trials)

abemaciclib (verzenio) (1 trial)

anastrozole (arimidex) (1 trial)

bismuth subsalicylate (1 trial)

budesonide (rhinocort) (1 trial)

cc-115 (1 trial)

cetuximab (erbitux) (1 trial)

colestipol (colestid) (1 trial)

crofelemer (mytesi) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

doxorubicin (Doxil) (2 trials)

fulvestrant (faslodex) (3 trials)

letrozole (femara) (1 trial)

loperamide (imodium) (3 trials)

mesalamine (rowasa) (1 trial)

neratinib maleate (nerlynx) (10 trials)

paclitaxel (taxol) (6 trials)

pertuzumab (perjeta) (1 trial)

temozolomide (temodar) (1 trial)

temsirolimus (torisel) (3 trials)

trastuzumab (herceptin) (7 trials)

trastuzumab emtansine (kadcyla) (1 trial)

valproic acid (depakene) (1 trial)

vinorelbine (navelbine) (2 trials)

digoxin (lanoxin) (1 trial)

everolimus (zortress) (1 trial)

fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)

lansoprazole (prevacid) (1 trial)

moxifloxacin (avelox) (1 trial)

niraparib (zejula) (1 trial)

palbociclib (ibrance) (1 trial)

trametinib (mekinist) (1 trial)